SuperworthUltralife ULBI
- Market cap
- $101.1M
- PE
- n/m
- not a meaningful number
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.5×
- EV/EBIT
- 36.2×
- Revenue, 12 months
- $187.2M
- +5% on a year ago
- Net margin
- −3.5%
- Free cash flow yield
- 2.0%
Ultralife trades at 0.5× sales. Revenue was $187.2M over the last twelve months, up 5% on a year earlier with a −3% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $39.5M+19% | $44.5M+23% | $41.9M+31% | $43M+1% | $35.7M−10% | $43.9M−2% | $50.7M+21% | $48.6M+13% | $43.4M+22% | $48.5M+11% | $47.4M−7% | $47.9M−1% | |
| Cost of revenue | $29.7M+12% | $33.1M+18% | $30.5M+24% | $31.4M−2% | $27M−9% | $33.3M+0% | $38M+25% | $37M+18% | $33.8M+25% | $36.4M+10% | $37.3M−2% | $34.1M−8% |
| Gross profit | $9.8M+46% | $11.4M+41% | $11.5M+54% | $11.6M+9% | $8.7M−11% | $10.6M−7% | $12.7M+11% | $11.6M+0% | $9.6M+11% | $12.1M+14% | $10.1M−21% | $13.9M+20% |
| R&D | $1.9M−1% | $1.9M+12% | $1.8M−14% | $2M+12% | $2.1M+12% | $2.4M+30% | $2.4M+37% | $2.3M+16% | $2.9M+36% | $2.8M+17% | $3M+23% | $3.2M+39% |
| SG&A | $5.8M+7% | $5.9M−5% | $5.7M+5% | $5.6M+10% | $6.1M+5% | $6.7M+14% | $6.9M+23% | $7M+24% | $7.7M+27% | $7.7M+14% | $7.4M+6% | $7.2M+3% |
| $2.1M | $3.6M+1582% | $4.1M+15527% | $3.9M+7% | $511K−76% | $1.5M−60% | $3.4M−16% | $2.3M−42% | −$951K | −$10.6M | −$215K | $3.4M+52% | |
| Interest expense | $586K+115% | $566K+54% | $520K+23% | $418K−5% | $173K−71% | $829K+47% | $1M+99% | $992K+137% | $992K+473% | $937K+13% | $868K−16% | $839K−15% |
| Pre-tax income | $1.7M | $3.1M | $3.6M | $3.8M−19% | $353K−80% | $495K−84% | $2.4M−32% | $1.1M−71% | −$1.8M | −$10.2M | −$663K | $3M+168% |
| $446K | $263K | $703K | $853K−38% | $74K−83% | $262K−0% | $567K−19% | $243K−72% | −$504K | −$2.8M | −$192K | $468K+93% | |
| Net income | $1.3M | $2.9M | $2.9M | $3M−11% | $258K−81% | $194K−93% | $1.9M−36% | $879K−70% | −$1.2M | −$7.4M | −$451K | $2.5M+189% |
| $0.08+167% | $0.18 | $0.08+167% | $0.18+500% | $0.02−75% | $0.01−94% | $11.00+13650% | $5.00+2678% | −$0.07 | −$0.45 | −$3.00 | $15.00+200% | |
| 16.3M+1% | 16.4M+2% | 16.5M+2% | 16.8M+4% | 16.9M+4% | 16.8M+3% | 16.7M+1% | 16.7M−1% | 16.6M−1% | 16.7M−1% | 16.7M−0% | 16.7M+0% |
Revenue: Q1 FY10: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY10: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY10: 6 months less the 3 months printed beside them.
R&D: Q1 FY10: 6 months less the 3 months printed beside them.
SG&A: Q1 FY10: 6 months less the 3 months printed beside them.
Operating income: Q1 FY10: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY10: 6 months less the 3 months printed beside them.
Income tax: Q1 FY10: 6 months less the 3 months printed beside them.
Net income: Q1 FY10 and Q1 FY11: 6 months less the 3 months printed beside them.
EPS, diluted: 16 periods, Q1 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY10: share-days: the 6-month average less the second quarter's. Q4 FY11: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution. 10 periods, Q4 FY12 to Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days. 3 periods, Q4 FY21 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Industrial - Machinery nearest Ultralife's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| ULBIUltralife | $101.1M | n/m | 18.8× | 0.5× | +5% | −3.5% | |
| PPIHPerma-Pipe International | $234.6M | 15.1× | 15.1× | 1.0× | +25% | 6.9% | |
| TWINTwin Disc | $354M | 13.0× | 17.2× | 0.9× | +12% | 7.1% | |
| LYTSLSI Industries | $755.3M | 30.3× | 24.2× | 1.1× | +20% | 3.3% | |
| GHMGraham | $775.8M | 63.6× | 60.7× | 3.0× | +21% | 4.5% | |
| Peer median | $554.7M | 22.7× | 20.7× | 1.1× | +21% | 5.7% |
More on Ultralife
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Industrial - Machinery
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .